Join the Eczema group to help and get support from people like you.
Eczema News (Page 2)
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
FRIDAY, Dec. 22, 2023 – From 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology. Samir Kamat, M.D., from...
One in Five New Dermatology Drugs Were First in Class Over the Past Decade
FRIDAY, Dec. 22, 2023 (HealthDay News) – From 2012 to 2022, innovative dermatologic drug development increased, according to a research letter published online Dec. 20 in JAMA Dermatology. ...
Recommendations Developed for Atopic Dermatitis Therapies
THURSDAY, Nov. 16, 2023 – In updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are...
Eczema Takes Big Toll on Mental Health, Survey Finds
THURSDAY, Nov. 9, 2023 – Eczema can be a burden on the mind as well the body, a new survey shows. People with eczema are more likely to experience depression and anxiety, and it worsens when...
Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab
MONDAY, Oct. 30, 2023 – For adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL),...
Children With Eczema More Likely to Have Allergic Contact Dermatitis
MONDAY, Oct. 2, 2023 – Children with atopic dermatitis (AD) are more likely to have positive patch test (PPT) reactions, according to a study published online Sept. 25 in the Journal of the American...
Kids With Eczema May Need Further Allergy Tests
FRIDAY, Sept. 29, 2023 – Some children who have a common form of eczema should also be tested for allergic reactions because they may have a second allergic-type eczema, a new study suggests. While...
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
TUESDAY, Sept. 26, 2023 – For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published...
Is It Eczema or Psoriasis? An Expert Offers Advice
FRIDAY, Sept. 8, 2023 – Eczema and psoriasis are skin conditions that can each affect a person’s quality of life. The best way to know which one you have if you have an itchy rash or burning feeling ...
Alterations in Infant Gut Microbiota Precede Development of Eczema
TUESDAY, Sept. 5, 2023 – The gut microbiome may play a role in development of eczema in infancy, according to a study published online Aug. 30 in mSystems. Man Kit Cheung, Ph.D., from the Chinese...
Vacations in the Sun Aren't Good for Your Skin's Microbiome
WEDNESDAY, Aug. 9, 2023 – It’s already known that the “healthy glow” of a tan actually represents damage to skin cells. But a new study of people on vacation has found that sunbathing also can disru...
FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupi...
FDA Approves Dupixent (dupilumab) for Eczema
March 28, 2017 – The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for...
FDA Approves Eucrisa (crisaborole) for Eczema
December 14, 2016 – The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older....
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
prednisone, methotrexate, clobetasol, fluocinonide, Dupixent, dexamethasone, desonide, halobetasol